Cargando…
Glycosaminoglycan Conjugation for Improving the Duration of Therapeutic Action of Glucagon-Like Peptide-1
[Image: see text] Glucagon-like peptide-1 (GLP-1) is an incretin peptide that plays a crucial role in lowering blood glucose levels and holds promise for treating type II diabetes. In this study, we synthesized GLP-1 derivatives that were conjugated with glycosaminoglycans (GAGs), i.e., chondroitin...
Autores principales: | Ichikawa, Megumi, Hirayama, Tetsuya, Fukushima, Masanobu, Kitazawa, Ikue, Kojima, Kazuhiro, Sakai, Tokiko, Takatsu, Yoshihiro, Ohtaki, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044901/ https://www.ncbi.nlm.nih.gov/pubmed/30023916 http://dx.doi.org/10.1021/acsomega.8b00467 |
Ejemplares similares
-
IR action spectroscopy of glycosaminoglycan oligosaccharides
por: Lettow, Maike, et al.
Publicado: (2019) -
Selectin-Targeting Peptide–Glycosaminoglycan Conjugates Modulate Neutrophil–Endothelial Interactions
por: Wodicka, James R., et al.
Publicado: (2018) -
Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation
por: Morla, Shravan
Publicado: (2019) -
Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicity
por: Christianson, Helena C., et al.
Publicado: (2017) -
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
por: Gaddi, Antonio V, et al.
Publicado: (2010)